- Home
- LMFA vs GNPX Comparison
LMFA vs GNPX Comparison
Compare LMFA & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- GNPX
- Stock Information
- Founded
- LMFA 2008
- GNPX 2009
- Country
- LMFA United States
- GNPX United States
- Employees
- LMFA N/A
- GNPX N/A
- Industry
- LMFA Finance: Consumer Services
- GNPX Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- GNPX Health Care
- Exchange
- LMFA Nasdaq
- GNPX Nasdaq
- Market Cap
- LMFA 7.0M
- GNPX 6.1M
- IPO Year
- LMFA 2015
- GNPX 2018
- Fundamental
- Price
- LMFA $1.30
- GNPX $0.30
- Analyst Decision
- LMFA Hold
- GNPX Strong Buy
- Analyst Count
- LMFA 1
- GNPX 1
- Target Price
- LMFA N/A
- GNPX $10.00
- AVG Volume (30 Days)
- LMFA 32.2K
- GNPX 6.0M
- Earning Date
- LMFA 05-15-2025
- GNPX 05-13-2025
- Dividend Yield
- LMFA N/A
- GNPX N/A
- EPS Growth
- LMFA N/A
- GNPX N/A
- EPS
- LMFA N/A
- GNPX N/A
- Revenue
- LMFA $10,555,948.00
- GNPX N/A
- Revenue This Year
- LMFA N/A
- GNPX N/A
- Revenue Next Year
- LMFA N/A
- GNPX N/A
- P/E Ratio
- LMFA N/A
- GNPX N/A
- Revenue Growth
- LMFA N/A
- GNPX N/A
- 52 Week Low
- LMFA $1.19
- GNPX $0.22
- 52 Week High
- LMFA $6.11
- GNPX $4.09
- Technical
- Relative Strength Index (RSI)
- LMFA 39.86
- GNPX 39.82
- Support Level
- LMFA $1.19
- GNPX $0.22
- Resistance Level
- LMFA $1.52
- GNPX $0.41
- Average True Range (ATR)
- LMFA 0.15
- GNPX 0.06
- MACD
- LMFA -0.00
- GNPX -0.00
- Stochastic Oscillator
- LMFA 23.61
- GNPX 25.00
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.